Difference between revisions of "Team:HokkaidoU Japan/Description"

Line 31: Line 31:
 
<li id="cite2">Masuda, K., Sakai, N., Nakamura, K., Yoshioka, S., & Ayabe, T. (2011). Bactericidal activity of mouse α-defensin cryptdin-4 predominantly affects noncommensal bacteria. <i>Journal of innate immunity</i>, 3(3), 315-326.</li>
 
<li id="cite2">Masuda, K., Sakai, N., Nakamura, K., Yoshioka, S., & Ayabe, T. (2011). Bactericidal activity of mouse α-defensin cryptdin-4 predominantly affects noncommensal bacteria. <i>Journal of innate immunity</i>, 3(3), 315-326.</li>
 
</ol>
 
</ol>
 
 
<h2> Project Description </h2>
 
 
<p>Tell us about your project, describe what moves you and why this is something important for your team.</p>
 
<br />
 
 
<h5>What should this page contain?</h5>
 
<ul>
 
<li> A clear and concise description of your project.</li>
 
<li>A detailed explanation of why your team chose to work on this particular project.</li>
 
<li>References and sources to document your research.</li>
 
<li>Use illustrations and other visual resources to explain your project.</li>
 
</ul>
 
 
 
<br />
 
<h4>Advice on writing your Project Description</h4>
 
 
<p>
 
We encourage you to put up a lot of information and content on your wiki, but we also encourage you to include summaries as much as possible. If you think of the sections in your project description as the sections in a publication, you should try to be consist, accurate and unambiguous in your achievements.
 
</p>
 
 
<p>
 
Judges like to read your wiki and know exactly what you have achieved. This is how you should think about these sections; from the point of view of the judge evaluating you at the end of the year.
 
</p>
 
 
 
<br />
 
<h4>References</h4>
 
<p>iGEM teams are encouraged to record references you use during the course of your research. They should be posted somewhere on your wiki so that judges and other visitors can see how you though about your project and what works inspired you.</p>
 
 
 
 
<h4>Inspiration</h4>
 
<p>See how other teams have described and presented their projects: </p>
 
 
<ul>
 
<li><a href="https://2014.igem.org/Team:Imperial/Project"> Imperial</a></li>
 
<li><a href="https://2014.igem.org/Team:UC_Davis/Project_Overview"> UC Davis</a></li>
 
<li><a href="https://2014.igem.org/Team:SYSU-Software/Overview">SYSU Software</a></li>
 
</ul>
 
  
 
</div>
 
</div>

Revision as of 12:02, 25 August 2015

Project Description

Overview

Background

Until now, more than million species of insects have been found on Earth, and it is said that insects occupy about 70% of animals living on Earth. Though they are most prospering animal on land, unlike vertebrates, they do not have acquired immunity using antibodies. Instead, insects developed innate immune system. After the long history since the first insect had appeared on Earth, it is said to have been very rare to have insects dye out due to microbes getting resistant of their immune system. Insects were able to have this success thanks to antimicrobial-peptides, or AMPs.

Antimicrobial-peptides (AMPs) are, as its name says, peptides that attack pathogenic microbes. They are usually several tens of amino acid residues long, and are positively charged since they usually have basic amino acids. This positive charge enables the peptides to interact with cell membranes, and makes a hole. Contents of the cell outflow form this hole and the cells get killed.

AMPs are found in wide range of spices, including humans. Many of these kills wide range of microbes, including fungi, gram-positive and negative bacteria.

Recently, multidrug-resistant microbes have been a big program. From the fact that using AMPs, we could kill these bacteria, AMPs have been studied well for new kind of medicine.

Besides chemosynthesis, methods using genetic engineering have been a big topic for mass-producing AMPs. Program here is that because AMPs kill bacteria, it is difficult to synthesize AMPs using bacteria, since it kills itself. Many research have done to solve this program, including co-expression with lactalbumin family and expression using inclusion body, which both showed decrease in cell toxicity. (S. Tomisawa et al., 2013 [1]) There is also a research on alpha-defnsin, kind of AMP expressed from paneth cell of small intestine, which says that alpha-definsin have a selectivity to kill microbes that is not a resident flora. (K. Masuda et al., 2011 [2])

Using these facts, we HokkaidoU_Japan decided to produce two kinds of AMPs, thanatin and alpha-defensin, using Escherichia coli and Lactobacillus casei.

Reference

  1. Tomisawa, S., Hojo, E., Umetsu, Y., Ohki, S., Kato, Y., Miyazawa, M., ... & Aizawa, T. (2013). Overexpression of an antimicrobial peptide derived from C. elegans using an aggregation-prone protein coexpression system. AMB Express, 3(1), 45.
  2. Masuda, K., Sakai, N., Nakamura, K., Yoshioka, S., & Ayabe, T. (2011). Bactericidal activity of mouse α-defensin cryptdin-4 predominantly affects noncommensal bacteria. Journal of innate immunity, 3(3), 315-326.

Link to iGEM HokkaidoU website main1 Link to iGEM HokkaidoU twitter
Link to iGEM HokkaidoU facebook page main5